🇺🇸 FDA
Patent

US 9200266

Methods and compositions for targeted single-stranded cleavage and targeted integration

granted A61KA61K38/00A61P

Quick answer

US patent 9200266 (Methods and compositions for targeted single-stranded cleavage and targeted integration) held by Sangamo Biosciences, Inc. expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61P, A61P31/12, A61P43/00